LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,544 | -0.6% | 52,759 | +2.1% | 0.27% | -4.3% |
| Q2 2023 | $3,567 | +34.7% | 51,679 | -5.9% | 0.28% | +46.1% |
| Q1 2023 | $2,648 | -57.9% | 54,913 | -87.8% | 0.19% | -63.1% |
| Q4 2022 | $6,290 | -99.5% | 450,576 | +1265.0% | 0.52% | +318.4% |
| Q3 2022 | $1,347,000 | -22.1% | 33,009 | +5.0% | 0.12% | -20.4% |
| Q2 2022 | $1,729,000 | +315.6% | 31,444 | +252.2% | 0.16% | +946.7% |
| Q4 2021 | $416,000 | – | 8,927 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |